InsiderClue
Stocks · Health care · Services-Commercial Physical & Biological Research

Charles River Laboratories

CRL Clue Score34
United States Fiscal year ends December CIK 0001100682 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Glenn Coleman
30 Sep 2026
EVP & Chief Financial Officer
Buy
10
$297.43
$2.97K
Joseph W LaPlume
3 Mar 2026
EVP, Corp Strategy & Develop
Buy
25
$174.54
$4.36K
Birgit Girshick
20 Feb 2025
Corporate Executive VP & COO
Buy
1,514
$164.63
$249.25K
James C Foster
20 Feb 2025
Chairman, President and CEO
Buy
6,075
$165.01
$1.00M
Birgit Girshick
20 Nov 2023
Corporate Executive VP & COO
Buy
1,322
$187.82
$248.30K
James C Foster
14 Nov 2023
Chairman, President and CEO
Buy
5,620
$178.05
$1.00M
Richard F Wallman
24 Aug 2023
Director
Buy indirect
1,000
$198.79
$198.79K
Richard F Wallman
23 Feb 2023
Director
Buy
1,750
$220.73
$386.28K
Richard F Wallman
2 Dec 2022
Director
Buy
1,500
$218.90
$328.35K
Showing 250 of 3,089 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 636
Amendments (4/A) skipped 17
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 1,164
Sales at will 1,895
Transactions with no price 0
Shares from compensation/vesting 3,885,335
Sales filed before the plan box existed 1,872
History held since 5 Oct 2006